Insider Transactions in Q4 2016 at Ra Pharmaceuticals, Inc. (RARX)
Insider Transaction List (Q4 2016)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Oct 31
2016
|
Novartis Bioventures LTD > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
84,615
+3.22%
|
$1,099,995
$13.0 P/Share
|
|
Oct 31
2016
|
Novartis Bioventures LTD > 10% Shareholder |
BUY
Conversion of derivative security
|
Direct |
2,398,462
+28.77%
|
-
|
|
Oct 31
2016
|
Novartis Bioventures LTD > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
339
-0.54%
|
$4,407
$13.0 P/Share
|
|
Oct 31
2016
|
Novartis Bioventures LTD > 10% Shareholder |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Direct |
62,914
+50.0%
|
$0
$0.07 P/Share
|